← Back to headlines
Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial
Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.
21 Feb, 17:31 — 21 Feb, 17:31
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Study Links Hidden Gut Virus to Increased Colorectal Cancer Risk
15m ago
Running — the one exercise that midlife women really need to do - The Times
2h ago
Katseye's Manon Takes Temporary Hiatus for Health Reasons
2h ago
FDA Grants Breakthrough Status to Johnson & Johnson's Cancer Drug for Advanced Head and Neck Cancer
2h ago